146 related articles for article (PubMed ID: 6627241)
1. Treatment of refractory malignant neoplasms with ifosfamide as single agent and in combination chemotherapy.
Retsas S
Cancer Treat Rev; 1983 Sep; 10 Suppl A():151-7. PubMed ID: 6627241
[No Abstract] [Full Text] [Related]
2. Ifosfamide--current aspects and perspectives.
Hilgard P; Herdrich K; Brade W
Cancer Treat Rev; 1983 Sep; 10 Suppl A():183-92. PubMed ID: 6414693
[No Abstract] [Full Text] [Related]
3. Treatment of refractory malignant lymphomas with ifosfamide/etoposide combination chemotherapy.
Scheulen ME; Bremer K; Niederle N; Seeber S
Cancer Treat Rev; 1983 Sep; 10 Suppl A():137-43. PubMed ID: 6627240
[TBL] [Abstract][Full Text] [Related]
4. Ifosfamide as single-agent chemotherapy in inoperable non-small-cell lung cancer.
Peake MD; Parker D
Lancet; 1985 Aug; 2(8453):496-7. PubMed ID: 2863510
[No Abstract] [Full Text] [Related]
5. Combination chemotherapy with adriamycin, ifosfamide and mesna in extensive-stage non-small cell bronchogenic carcinoma.
Matthiessen W; Stempinski E; Göbel D; Thalmann U
Cancer Treat Rev; 1983 Sep; 10 Suppl A():121-3. PubMed ID: 6414688
[No Abstract] [Full Text] [Related]
6. Ifosfamide in small cell lung cancer.
Einhorn LH
Semin Oncol; 1989 Feb; 16(1 Suppl 3):19-21. PubMed ID: 2539644
[TBL] [Abstract][Full Text] [Related]
7. Ifosfamide studies for primary or recurrent pediatric malignant solid tumors and leukemia.
Pratt CB
Semin Oncol; 1990 Apr; 17(2 Suppl 4):31-40. PubMed ID: 2185546
[TBL] [Abstract][Full Text] [Related]
8. Ifosfamide: European perspective.
Burkert H
Semin Oncol; 1982 Dec; 9(4 Suppl 1):28-35. PubMed ID: 6761866
[No Abstract] [Full Text] [Related]
9. [Toxic-allergic lung edema following cyclophosphamide and ifosfamide therapy. Case report].
Kehl A; Bergholz M; von Heyden HW; Nagel GA
Onkologie; 1983 Apr; 6(2):84-6. PubMed ID: 6306532
[No Abstract] [Full Text] [Related]
10. Overview of ifosfamide in small cell and non-small cell lung cancer.
Johnson DH
Semin Oncol; 1990 Apr; 17(2 Suppl 4):24-30. PubMed ID: 2159187
[TBL] [Abstract][Full Text] [Related]
11. Overview of ifosfamide in small cell lung cancer.
Ettinger DS
Semin Oncol; 1992 Feb; 19(1 Suppl 1):59-67. PubMed ID: 1329214
[TBL] [Abstract][Full Text] [Related]
12. [Clinical experience with the cytostatic drug ifosfamide].
Ritter S; Schröder HJ
Med Welt; 1977 Sep; 28(35):1395-1400. PubMed ID: 70737
[No Abstract] [Full Text] [Related]
13. Treatment of advanced bone marrow neoplasms with ifosfamide combinations.
Norberg B; Holm J; Winqvist E; Wahlin A
Scand J Haematol; 1984 Jan; 32(1):95-100. PubMed ID: 6582586
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of ifosfamide in children with malignant solid tumors.
Pratt CB; Horowitz ME; Meyer WH; Etcubanas E; Thompson EI; Douglass EC; Wilimas JA; Hayes FA; Green AA
Cancer Treat Rep; 1987 Feb; 71(2):131-5. PubMed ID: 3100034
[TBL] [Abstract][Full Text] [Related]
15. Phase I clinical trial of a 3-day divided dose schedule of ifosfamide (NSC 109724).
Nelson RL; Creaven PJ; Cohen MH; Fossieck BE
Eur J Cancer (1965); 1976 Mar; 12(3):195-8. PubMed ID: 780113
[No Abstract] [Full Text] [Related]
16. [Experience with fractionate massive-dose Ifosfamid therapy of generalized malignant tumors].
Hoefer-Janker H; Scheef W; Günther U; Hüls W
Med Welt; 1975 May; 26(20):972-9. PubMed ID: 1094226
[No Abstract] [Full Text] [Related]
17. Combined chemotherapy with ifosfamide and cisplatin and with ifosfamide and etoposide (VP-16) in non-small cell carcinoma of the bronchus.
Manke HG; Drings P; Stiefel P; Schmitteckert H; Grimm V; Kleckow M
Cancer Treat Rev; 1983 Sep; 10 Suppl A():125-8. PubMed ID: 6684989
[No Abstract] [Full Text] [Related]
18. Ifosfamide, methotrexate, and vincristine (IMV) combination chemotherapy as secondary treatment for patients with malignant lymphoma.
Cabanillas F; Rodriguez V; Bodey GP
Cancer Treat Rep; 1980; 64(8-9):933-7. PubMed ID: 7004634
[No Abstract] [Full Text] [Related]
19. Ifosfamide in the treatment of non-small cell lung cancer.
Ettinger DS
Semin Oncol; 1989 Feb; 16(1 Suppl 3):31-8. PubMed ID: 2539646
[TBL] [Abstract][Full Text] [Related]
20. Ifosfamide and etoposide as salvage therapy for non-Hodgkin's lymphoma.
Hagberg H; Cavallin-Ståhl E; Lind J
Scand J Haematol; 1986 Jan; 36(1):61-4. PubMed ID: 3952466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
